FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308333923> ?p ?o ?g. }

• W4308333923 endingPage "430" @default.
• W4308333923 startingPage "430" @default.
• W4308333923 abstract "Generalised anxiety disorder (GAD) is a common anxiety disorder associated with social and occupational impairment. Recently, a theory was postulated that dysfunctional gamma aminobutyric acid type A receptors (GABAA) are implicated in anxiety symptomology, which could be corrected by flumazenil, an antagonist at the benzodiazepine binding site on the GABAA receptor.Participants had a primary diagnosis of GAD and were treated initially with an eight-day continuous low-dose flumazenil infusion (total 32 mg at a rate of 4 mg/24 h). Some participants were re-treated with a further four- or eight-day infusion. Treatment response was measured as a 50% reduction in anxiety or stress scores on the Depression Anxiety Stress Scale-21 (DASS-21). Remission was measured as scores ≤3 or ≤7 on the anxiety and stress subscales of the DASS-21, respectively.Eight cases are reported. All cases met the criteria for treatment response on the anxiety and stress subscale of the DASS-21. Remission was achieved in seven participants on the anxiety subscale and in five on the stress subscale. No changes in hepatic, renal, or haematological function were likely attributed to flumazenil.Data suggest that low-dose continuous flumazenil infusion manages GAD symptoms and is safe. Although these results are promising, future randomised control trials are required to confirm these results." @default.
• W4308333923 created "2022-11-11" @default.
• W4308333923 creator A5007756290 @default.
• W4308333923 creator A5022362462 @default.
• W4308333923 creator A5023402987 @default.
• W4308333923 creator A5032438740 @default.
• W4308333923 creator A5033652669 @default.
• W4308333923 creator A5046408523 @default.
• W4308333923 creator A5069960608 @default.
• W4308333923 creator A5079058456 @default.
• W4308333923 date "2022-11-02" @default.
• W4308333923 modified "2023-10-14" @default.
• W4308333923 title "Long-Term Management of Generalised Anxiety Disorder with Low-Dose Continuous Infusions of Flumazenil: A Case Series" @default.
• W4308333923 cites W1942827836 @default.
• W4308333923 cites W1968427184 @default.
• W4308333923 cites W1970818880 @default.
• W4308333923 cites W1971325694 @default.
• W4308333923 cites W1971774209 @default.
• W4308333923 cites W1989257227 @default.
• W4308333923 cites W1993904321 @default.
• W4308333923 cites W2004241099 @default.
• W4308333923 cites W2009410204 @default.
• W4308333923 cites W2010561328 @default.
• W4308333923 cites W2011145198 @default.
• W4308333923 cites W2026362148 @default.
• W4308333923 cites W2027570313 @default.
• W4308333923 cites W2031231452 @default.
• W4308333923 cites W2042306138 @default.
• W4308333923 cites W2071967920 @default.
• W4308333923 cites W2072370095 @default.
• W4308333923 cites W2074924866 @default.
• W4308333923 cites W2080743918 @default.
• W4308333923 cites W2083164476 @default.
• W4308333923 cites W2088959265 @default.
• W4308333923 cites W2088994872 @default.
• W4308333923 cites W2090425320 @default.
• W4308333923 cites W2091589270 @default.
• W4308333923 cites W2123921426 @default.
• W4308333923 cites W2160759787 @default.
• W4308333923 cites W2161731199 @default.
• W4308333923 cites W2173125490 @default.
• W4308333923 cites W2491485116 @default.
• W4308333923 cites W2762198951 @default.
• W4308333923 cites W2803191377 @default.
• W4308333923 cites W2803692240 @default.
• W4308333923 cites W2890503810 @default.
• W4308333923 cites W2986082729 @default.
• W4308333923 cites W3038819475 @default.
• W4308333923 cites W3044475748 @default.
• W4308333923 cites W4224995096 @default.
• W4308333923 cites W4241665064 @default.
• W4308333923 cites W4280538113 @default.
• W4308333923 cites W4285302773 @default.
• W4308333923 cites W4303709762 @default.
• W4308333923 cites W4320578730 @default.
• W4308333923 doi "https://doi.org/10.3390/bs12110430" @default.
• W4308333923 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36354407" @default.
• W4308333923 hasPublicationYear "2022" @default.
• W4308333923 type Work @default.
• W4308333923 citedByCount "0" @default.
• W4308333923 crossrefType "journal-article" @default.
• W4308333923 hasAuthorship W4308333923A5007756290 @default.
• W4308333923 hasAuthorship W4308333923A5022362462 @default.
• W4308333923 hasAuthorship W4308333923A5023402987 @default.
• W4308333923 hasAuthorship W4308333923A5032438740 @default.
• W4308333923 hasAuthorship W4308333923A5033652669 @default.
• W4308333923 hasAuthorship W4308333923A5046408523 @default.
• W4308333923 hasAuthorship W4308333923A5069960608 @default.
• W4308333923 hasAuthorship W4308333923A5079058456 @default.
• W4308333923 hasBestOaLocation W43083339231 @default.
• W4308333923 hasConcept C118552586 @default.
• W4308333923 hasConcept C126322002 @default.
• W4308333923 hasConcept C15744967 @default.
• W4308333923 hasConcept C170493617 @default.
• W4308333923 hasConcept C27502469 @default.
• W4308333923 hasConcept C2776006611 @default.
• W4308333923 hasConcept C2776317618 @default.
• W4308333923 hasConcept C2778173252 @default.
• W4308333923 hasConcept C2778409475 @default.
• W4308333923 hasConcept C2779911313 @default.
• W4308333923 hasConcept C558461103 @default.
• W4308333923 hasConcept C71924100 @default.
• W4308333923 hasConceptScore W4308333923C118552586 @default.
• W4308333923 hasConceptScore W4308333923C126322002 @default.
• W4308333923 hasConceptScore W4308333923C15744967 @default.
• W4308333923 hasConceptScore W4308333923C170493617 @default.
• W4308333923 hasConceptScore W4308333923C27502469 @default.
• W4308333923 hasConceptScore W4308333923C2776006611 @default.
• W4308333923 hasConceptScore W4308333923C2776317618 @default.
• W4308333923 hasConceptScore W4308333923C2778173252 @default.
• W4308333923 hasConceptScore W4308333923C2778409475 @default.
• W4308333923 hasConceptScore W4308333923C2779911313 @default.
• W4308333923 hasConceptScore W4308333923C558461103 @default.
• W4308333923 hasConceptScore W4308333923C71924100 @default.
• W4308333923 hasIssue "11" @default.
• W4308333923 hasLocation W43083339231 @default.
• W4308333923 hasLocation W43083339232 @default.
• W4308333923 hasLocation W43083339233 @default.

• next